Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Frontiers in Immunology|July 9, 2019
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus MonkeysDiethilde Theil, Paul Smith, Catherine Huck, et al.
The Lancet. Neurology|July 31, 2023
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation studyAhmed Abdelhak, Franziska Petermeier, Pascal Benkert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2021
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension studyHans-Peter Hartung, Tobias Derfuss, Bruce Ac Cree, et al.
Archives of Neurology|September 13, 2006
Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutationsLianna Ishihara, Liling Warren, Rachel Gibson, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosisTanuja Chitnis, Cindy Gonzalez, Brian C Healy, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypothesesGavin Giovannoni, Gary Cutter, Maria Pia Sormani, et al.
Frontiers in Neuroscience|May 2, 2022
Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial FibrillationAlexandros A Polymeris, Fabrice Helfenstein, Pascal Benkert, et al.
Nature Reviews. Neurology|April 12, 2024
Neurofilaments as biomarkers in neurological disorders - towards clinical applicationMichael Khalil, Charlotte E Teunissen, Sylvain Lehmann, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activitySofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
Pageof 16